HYPERION THERAPEUTICS INC — Form D

HYPERION THERAPEUTICS INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-04. The offering totals $15.0M, of which $7.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Gaurav AggarwalDirectorPalo Alto, CA
David GryskaDirectorDallas, TX
Bo Jesper HansenDirectorWestlake Village, CA
James HealyDirectorSunnyvale, CA
Robert HopfnerDirectorPalo Alto, CA
Jake NunnDirectorMenlo Park, CA
Bijan SalehizadehDirectorBETHESDA, MD
Donald SantelDirectorSan Diego, CA
Lota ZothDirectorSouth San Francisco, CA
Klara DickinsonExecutive OfficerSouth San Francisco, CA
Jeffrey FarrowExecutive OfficerSouth San Francisco, CA
Christine NashExecutive OfficerSouth San Francisco, CA
Donald SantelExecutive OfficerSan Diego, CA
Bruce ScharschmidtExecutive OfficerSouth San Francisco, CA
Rob HopfnerDirectorSan Diego, CA
James I HealyDirectorDORADO, PR
CHRISTINE A NASHExecutive OfficerNEW HAVEN, CT
Daniel PerezDirectorSan Francisco, CA
Donald J SantelExecutive OfficerSan Diego, CA
Jake R NunnDirectorSan Diego, CA
Bijan R SalehizadehDirectorChicago, IL
Lota S ZothDirectorLa Jolla, CA
Bo Jesper I HansenDirectorBrisbane, CA
Natalie A HollesExecutive OfficerBrisbane, CA
Daniel G WelchDirectorBrisbane, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2014-06-18D$8.0M$8.0M
2011-04-18D$35.0M$17.5M
2009-07-16D$45.5M$22.0M
2009-05-14D$15.0M$13.0M

More